Skip to Main Content

Paper Details

Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies.
Front Immunol
3
2021
Author NameAffiliation
Dietger NiederwieserUniversity Hospital Leipzig
  • 1 - 1

Datasets

Release 1.2